{
    "2021-03-07": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Genmab: A Company With Downside Antibodies",
                "features": {
                    "keywords": [
                        "Genmab",
                        "Downside",
                        "Antibodies"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "5 High-Yield Dividend Stocks to Buy for a Biden Bull Market",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Dividend",
                        "Biden",
                        "Bull Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "dividend stocks",
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}